First Command Advisory Services’s AstraZeneca AZN Stock Holding History

First Command Advisory Services's AZN Position: Q2 2026 in Review

First Command Advisory Services increased its AstraZeneca (AZN) stake by 2,236% in Q2 2026, buying an estimated $105K and bringing the position to 584 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

First Command Advisory Services first reported a position in AZN in Q1 2024 and has held it in 5 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

• First Command Advisory Services held 584 shares of AstraZeneca worth $109K as of Q2 2026.
• First Command Advisory Services bought 559 AstraZeneca shares in Q2 2026, an estimated $105K.
• AstraZeneca made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #293 holding.
• First Command Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 5 quarters since.
• 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.